Sunshine Biopharma (SBFM) Gross Margin (2018 - 2026)
Sunshine Biopharma (SBFM) recorded Gross Margin of 26.20% in Q2 2026, down 10.18 percentage points from 36.37% a year earlier and down 0.77 percentage points from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Gross Margin (2018 - 2026) Analysis & Trends
On a TTM basis, Sunshine Biopharma's Gross Margin came in at 30.30% as of Jun 30, 2026, down 3.03 percentage points year-over-year; for FY2025, it was 33.76%, up 3.16 percentage points from FY2024.
- Annual Gross Margin has a five-year change of -30.05 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 30.60% in FY2024 (-4.02 pp), 34.61% in FY2023 (-4.43 pp), 39.04% in FY2022 (-9.38 pp) and 48.42% in FY2021 (-15.39 pp).
- The Q2 2026 figure is the lowest quarterly Gross Margin since Q2 2024.
- On a year-over-year basis, Gross Margin rose in three of the last eight quarters, with an average year-over-year change of -0.29 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 11.05 percentage points in Q2 2025, against a drop of 34.65 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 26.96% (Q1 2026), 35.31% (Q4 2025) and 32.64% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Sunshine Biopharma | 1.12 Mn | -37.97 Mn | 2.43 Mn | 26.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.20% |
| Mar 31, 2026 | 26.96% |
| Dec 31, 2025 | 35.31% |
| Sep 30, 2025 | 32.64% |
| Jun 30, 2025 | 36.37% |
| Mar 31, 2025 | 30.67% |
| Dec 31, 2024 | 32.24% |
| Sep 30, 2024 | 33.98% |
| Jun 30, 2024 | 25.33% |
| Mar 31, 2024 | 31.22% |
| Dec 31, 2023 | 33.44% |
| Sep 30, 2023 | 33.41% |
| Jun 30, 2023 | 35.12% |
| Mar 31, 2023 | 37.35% |
| Dec 31, 2022 | 37.85% |
| Sep 30, 2022 | 50.47% |
| Jun 30, 2022 | 50.31% |
| Mar 31, 2022 | 51.20% |
| Dec 31, 2021 | 28.00% |
| Sep 30, 2021 | 61.28% |
API Access
Sunshine Biopharma Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();